Pharmaceutical Drug Delivery Market to hit USD 3.2 Trillion by 2032, says Global Market Insights Inc.
May 03, 2023 08:10 ET
|
Global Market Insights Inc.
Selbyville, Delaware, May 03, 2023 (GLOBE NEWSWIRE) -- The pharmaceutical drug delivery market value is predicted to reach over USD 3.2 trillion by 2032, according to a new research report by...
Global Western Blotting Processors Market to Reach USD 1.94 Billion by 2030
April 25, 2023 19:00 ET
|
DataM Intelligence
Ohio, Cleveland, April 25, 2023 (GLOBE NEWSWIRE) -- Market Overview: Western blotting is a crucial process for the immunodetection of proteins, specifically proteins that are in low quantity. This...
Provectus Biopharmaceuticals Announces Publication of Activity of Pharmaceutical-Grade Rose Bengal Sodium (RBS) Against Colistin-Resistant Gram-Negative Bacteria
April 20, 2023 08:00 ET
|
Provectus Biopharmaceuticals Inc.
Colistin is used as last-resort treatment for bacterial infectionsProvectus’ RBS effectively inhibits growth of colistin-resistant G- bacteriaRBS also possesses rapid-killing feature KNOXVILLE, TN,...
Infectious Disease Connect Develops Novel Antibiogram Tool to Improve Empiric Antibiotic Prescribing in Skilled Nursing Facilities
April 11, 2023 08:00 ET
|
Infectious Disease Connect
PITTSBURGH, PA, April 11, 2023 (GLOBE NEWSWIRE) -- Researchers from the University of Wisconsin-Madison and the University of Pittsburgh School of Medicine are leading a six-month study to explore...
Penicillin G Acylase Market to Surpass USD 1.1 Bn Revenue by 2031 | Exclusive Research by TMR
April 04, 2023 15:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, April 04, 2023 (GLOBE NEWSWIRE) -- According to the latest research by Transparency Market Research, the global penicillin G acylase market was valued at USD...
Icosavax Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
March 30, 2023 16:05 ET
|
Icosavax, Inc.
- FDA granted Fast Track Designation for IVX-A12, a bivalent respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) VLP vaccine candidate - - Completed dosing in ongoing Phase 1 study of...
Active Pharmaceutical Ingredients Market to hit USD 453.5 billion by 2032, says Global Market Insights Inc.
March 20, 2023 02:10 ET
|
Global Market Insights Inc.
Selbyville, Delaware, March 20, 2023 (GLOBE NEWSWIRE) -- Active pharmaceutical ingredients market value is estimated to surpass USD 453.5 billion by 2032, according to a new research report by...
BiondVax to Present at BIO-Europe Spring
March 16, 2023 13:10 ET
|
BiondVax Pharmaceuticals Ltd.
JERUSALEM, March 16, 2023 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing...
Icosavax to Participate in the Upcoming Healthcare Conferences
February 28, 2023 08:00 ET
|
Icosavax, Inc.
SEATTLE, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines...
Immunocore announces initial Phase 1 safety and pharmacodynamic activity data with first soluble TCR therapy for people living with HIV
February 22, 2023 07:00 ET
|
Immunocore Holdings Limited
Immunocore announces initial Phase 1 safety and pharmacodynamic activity data with first soluble TCR therapy for people living with HIV Data from the single ascending dose part of the Phase 1 trial...